Home › Interstitial Lung Diseases › District of Columbia
Pag-aaral pangklinika para sa Interstitial Lung Diseases sa District of Columbia
5 pag-aaral para sa Interstitial Lung Diseases ang naghahanap ng mga kalahok sa mga site sa District of Columbia.
Mga Lungsod sa District of Columbia
Opisyal na teksto ng pag-aaral (English)
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Washington D.C.
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05878717DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Pasquerilla Healthcare Center - Georgetown University, Washington D.C.
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Georgetown University Medical Center - Department of Rheumatology, Washington D.C.
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT06195072A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- George Washington University Medical, Washington D.C.
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07175038Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Georgetown University Hospital, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT05943535Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.